This new agreement, awarded through a public tender process is a testament to the exceptional service Slade provides to over 30 public hospitals in SA Health which span across metropolitan and regional areas.
Slade Health secures five-year extension as sole supplier of compounded pharmaceuticals for South Australia’s public hospitals
Slade Health first won sole supplier for chemotherapy in 2016 extending to all categories (chemotherapy, antibiotics and analgesic) in 2019.
Best-in-class services
This extension further reinforces our commitment to South Australia with our purpose-built TGA licensed facility in Woodville. Now in its third year, the facility delivers more than 650 compounded products a day, totalling 53,000 essential medications and 8,000 deliveries across the state to public and private facilities. Our South Australian offering complements our facilities in Queensland, New South Wales, Victoria and Auckland, cementing our position as market leaders.
CEO of Pharmacy and Compounding, Russell Hill said this reflects Slade’s market-leading reputation.
“This extension highlights the strong trust we have built over the years with our hospital partners and continues our commitment to the region,” said Russell.
“Our proven processes and dedication to producing the highest quality products across our network of TGA-licensed facilities allows us to deliver state-wide contracts and service over 200 hospitals across Australia and New Zealand.”
Excellence in healthcare
This year the Slade brand, underpinned by Slade Pharmacy, celebrates 60 years of delivering pharmacy and compounding services and continues to focus on innovative solutions leading the way in specialised pharmaceutical services.
Slade Health General Manager – Client Relations, Paula Clark congratulates the team.
“We have a strong focus on listening to our customers and hospital partners and delivering a service that meets their needs,” said Paula.
“It’s that commitment to customer service, innovation and patient-centred care that drive the team and continue to deliver more care, to more people.”